Zacks.com featured highlights include LifeStance Health, Tutor Perini, News, Everus Construction and HF Sinclair

Rising Middle East-related supply disruptions pushed Brent crude above $100/bbl, while the 10-year Treasury yield reached 4.836%, increasing inflation concerns and expectations for additional Fed tightening. Zacks recommends low-leverage names LFST, TPC, NWS, ECG and DINO as defensive selections; consensus 2026/2027 earnings-growth estimates range from 11% for News Corp. to 700% for LifeStance. Supporting catalysts include LifeStance's 26% Q2 revenue growth, News Corp.'s 84.2% EPS growth, Everus's $295M Epsilon acquisition, and HF Sinclair's Western Gateway Pipeline investment decision.

Analysis

The screen confuses accounting leverage with rate sensitivity. LFST’s value is dominated by the path to sustained clinic-level profitability and payer reimbursement; higher real yields can still compress its long-duration multiple despite limited balance-sheet risk. NWS is the cleaner defensive expression: recurring Dow Jones and digital-real-estate cash flows have lower direct energy exposure, while a weaker consumer environment could pressure ad-linked businesses and book demand. Neither warrants buying solely on a rank-based earnings-growth statistic.

DINO has the most direct near-term earnings torque, but refinery equities monetize product-crack spreads rather than crude prices. A supply shock that raises crude faster than gasoline/diesel can compress margins, particularly if demand elasticity emerges; the Western pipeline project is a multi-year reliability option, not a 1-3 month EPS catalyst. PSX is a preferable liquid pair short against DINO if regional Western product tightness widens DINO’s realized-margin advantage, while KMI benefits only if incremental pipeline utilization and tariff escalators outrun financing-cost pressure.

ECG and TPC are nominal infrastructure beneficiaries but are not inflation defensives: fixed-price backlog, labor availability, bonding capacity, and working-capital demands determine whether revenue converts to cash. ECG’s acquisition adds integration and leverage risk precisely when construction multiples are yield-sensitive; TPC’s Middle East exposure also embeds execution, payment, and geopolitical risk. Over 6-18 months, grid hardening, data-center power demand, and modularization favor ECG more than broad nonresidential construction, but the thesis requires margin retention rather than backlog growth.

Consensus is likely to chase the “low leverage” label after a macro drawdown. The better setup is selective quality plus a hedge against renewed rate pressure: avoid treating debt-to-equity as comparable across service, media, refining, and contractors. Falsifiers are a sustained decline in 10-year yields below 4.4%, which would favor duration-sensitive LFST/ECG; refinery crack-spread contraction; or contractor gross-margin/operating-cash-flow misses in the next two reporting cycles.

Key Decisions for Investors

• Initiate a 1-3 month long NWS / short LFST pair, sized beta-neutral. NWS offers more resilient cash-flow composition under sticky rates; cover if LFST delivers two consecutive quarters of positive EBITDA/FCF conversion or if the 10-year yield falls below 4.4%.
• Do not chase DINO on crude direction alone. Establish a watch alert for a widening DINO-versus-PSX valuation gap alongside sustained Rocky Mountain/West Coast crack-strength; then buy DINO and short PSX for 3-6 months. Exit if cracks fall 15% from entry or crude rises while wholesale product prices fail to follow.
• Accumulate ECG only after the next earnings release confirms acquired-business integration, stable gross margin, and operating cash flow consistent with reported earnings. Use a 6-18 month horizon; reduce on margin-guide cuts or material net-debt/EBITDA expansion. TPC is a lower-quality substitute given project-concentration and contract-execution risk.
• Maintain KMI as an infrastructure-income hedge rather than a pure oil bullish trade; add only if management demonstrates volume-led EBITDA growth sufficient to offset refinancing costs. A further yield breakout without corresponding throughput evidence is a reason to avoid the name.